Articles written by: Rhonda Roth

Dova Pharmaceuticals Inc. (DOVA)’s Financial Results Comparing With Kamada Ltd. (NASDAQ:KMDA)

Since Dova Pharmaceuticals Inc. (NASDAQ:DOVA) and Kamada Ltd. (NASDAQ:KMDA) are part of the Biotechnology industry, they are influenced by compare. The influences particularly affect the profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership of both companies. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Theravance Biopharma Inc. (TBPH)’s Financial Results Comparing With Sierra Oncology Inc. (NASDAQ:SRRA)

This is therefore a comparing of the dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership in Theravance Biopharma Inc. (NASDAQ:TBPH) and Sierra Oncology Inc. (NASDAQ:SRRA). The two are both Biotechnology companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Comparison of Mountain Province Diamonds Inc. (MPVD) and Emerge Energy Services LP (NYSE:EMES)

Both Mountain Province Diamonds Inc. (NASDAQ:MPVD) and Emerge Energy Services LP (NYSE:EMES) are Industrial Metals & Minerals companies, competing one another. We will compare their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mountain […]

Bioblast Pharma Ltd. (ORPN)’s Financial Results Comparing With Chiasma Inc. (NASDAQ:CHMA)

Bioblast Pharma Ltd. (NASDAQ:ORPN) and Chiasma Inc. (NASDAQ:CHMA) compete against each other in the Biotechnology sector. We will contrast them and contrast their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bioblast Pharma Ltd. […]

H.B. Fuller Company (FUL) and PolyOne Corporation (NYSE:POL) Contrasting side by side

As Specialty Chemicals companies, H.B. Fuller Company (NYSE:FUL) and PolyOne Corporation (NYSE:POL) are our subject to contrast. And more specifically their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio H.B. Fuller Company 3.04B 0.80 […]

Reviewing Eyenovia Inc. (EYEN)’s and Tyme Technologies Inc. (NASDAQ:TYME)’s results

Eyenovia Inc. (NASDAQ:EYEN) and Tyme Technologies Inc. (NASDAQ:TYME), both competing one another are Biotechnology companies. We will compare their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Eyenovia Inc. N/A 0.00 13.23M -1.43 0.00 […]

Altaba Inc. (AABA) and Wells Fargo Advantage Utilities and High Income Fund (NYSEAMERICAN:ERH) Contrasting side by side

Since Altaba Inc. (NASDAQ:AABA) and Wells Fargo Advantage Utilities and High Income Fund (NYSEAMERICAN:ERH) are part of the Asset Management industry, they are influenced by compare. The influences particularly affect the risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation of both companies. Earnings and Valuation Gross Revenue Price/Sales […]

Generac Holdings Inc. (GNRC)’s Financial Results Comparing With Tennant Company (NYSE:TNC)

We will be contrasting the differences between Generac Holdings Inc. (NYSE:GNRC) and Tennant Company (NYSE:TNC) as far as institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation are concerned. The two businesses are rivals in the Diversified Machinery industry. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings […]

Cerus Corporation (CERS) and Repligen Corporation (NASDAQ:RGEN) Comparing side by side

Both Cerus Corporation (NASDAQ:CERS) and Repligen Corporation (NASDAQ:RGEN) are each other’s competitor in the Biotechnology industry. Thus the compare of their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cerus Corporation 60.91M 13.83 57.56M […]

Contrasting of Exelixis Inc. (EXEL) and Ocular Therapeutix Inc. (NASDAQ:OCUL)

As Biotechnology companies, Exelixis Inc. (NASDAQ:EXEL) and Ocular Therapeutix Inc. (NASDAQ:OCUL) are our subject to contrast. And more specifically their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Exelixis Inc. 853.83M 8.16 690.07M 2.21 […]